Research Reports

Key takeaways

Board authorized 9% global workforce reduction on April 24, 2026, as part of Project Nexus to transform operating model and cut costs.

Linda Llewelyn ceasing as Chief People Officer effective June 1, 2026, due to role elimination in workforce reduction.

Ms. Llewelyn to serve as senior advisor from June 2 to September 1, 2026, under anticipated separation and contractor agreements.

Separation benefits per Executive Severance Plan, summarized in May 19, 2025 proxy statement.

Initiative also eliminates ~100 open budgeted headcount positions in US and India.

Full analysis

The departure of Chief People Officer Linda Llewelyn aligns with Project Nexus, a strategic initiative to simplify Health Catalyst's organizational structure and focus resources on key technology opportunities. The 9% workforce reduction, including elimination of her role and 100 open positions, signals meaningful cost structure improvements. Investors should note the smooth transition plan via a senior advisor role and standard severance benefits, minimizing disruption to HR functions during this restructuring. Further details will appear in the upcoming 10-Q.

HCAT · Health Catalyst, Inc.

Summary

Key takeaways

Full analysis